Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, No.225, Changhai Road, Shanghai, China.
World J Surg. 2014 Apr;38(4):947-57. doi: 10.1007/s00268-013-2365-2.
The aim of this study was to investigate the prognostic value of tumor size alone on long-term survival and recurrence after curative resection for solitary hepatocellular carcinoma (HCC) without macroscopic vascular invasion.
A single-center cohort of 615 patients with solitary HCC (a single tumor, without macroscopic vascular invasion or distant metastasis) undergoing curative hepatic resection from 2002 to 2010 was retrospectively studied. Using 2.0, 3.0, 4.0, 5.0, 8.0, and 10.0 cm as cut-off values of tumor size, the overall survival (OS) and recurrence-free survival (RFS) rates were compared between the groups of patients with tumor size up to a certain cut-off value and the groups of patients with tumor size above that cut-off value. Thus, multiple comparisons were done. The prognostic factors of OS and RFS were evaluated using univariate and multivariate analyses.
The median tumor size of all HCCs was 4.0 cm (range 0.9-22.0 cm). The in-hospital mortality rate was 1.0 %, and the overall morbidity rate was 22.3 %. The 1-, 3-, and 5-year OS rates were 96.0, 79.8, and 69.9 %, and the corresponding RFS rates were 83.6, 72.7, and 57.2 %, respectively. On univariate analyses, the 1-, 3-, and 5-year OS and RFS rates were significantly different between the individual two groups of patients as divided by the aforementioned different cut-off values of tumor sizes (all p < 0.05). However, when tumor size was put as a continuous variable into multivariate analysis, it was no longer an independent prognostic factor of OS or RFS after curative resection.
Tumor size did not independently affect long-term survival and recurrence after curative resection of solitary HCC without macroscopic vascular invasion. Therefore, there is no size limit that precludes hepatic resection for solitary HCC, provided the tumor is resectable.
本研究旨在探讨无大血管侵犯的单发肝细胞癌(HCC)根治性切除术后肿瘤大小对长期生存和复发的预测价值。
回顾性分析 2002 年至 2010 年间接受根治性肝切除术的 615 例单发 HCC(单个肿瘤,无大血管侵犯或远处转移)患者的单中心队列研究。采用 2.0、3.0、4.0、5.0、8.0 和 10.0cm 作为肿瘤大小的截止值,比较肿瘤大小达到一定截止值的患者组和肿瘤大小超过该截止值的患者组的总生存率(OS)和无复发生存率(RFS)。因此,进行了多次比较。采用单因素和多因素分析评估 OS 和 RFS 的预后因素。
所有 HCC 的中位肿瘤大小为 4.0cm(范围 0.9-22.0cm)。住院死亡率为 1.0%,总发病率为 22.3%。1、3 和 5 年 OS 率分别为 96.0%、79.8%和 69.9%,相应的 RFS 率分别为 83.6%、72.7%和 57.2%。单因素分析显示,根据上述不同肿瘤大小的截止值,两组患者的 1、3 和 5 年 OS 和 RFS 率差异均有统计学意义(均 P<0.05)。然而,当肿瘤大小作为连续变量纳入多因素分析时,它不再是根治性切除术后 OS 或 RFS 的独立预后因素。
肿瘤大小不独立影响无大血管侵犯的单发 HCC 根治性切除术后的长期生存和复发。因此,只要肿瘤可切除,无大小限制可阻止对单发 HCC 进行肝切除术。